Use of Neuromodulation to Treat Post-COVID Neuropathic Pain: A Case Report.
Given the results of this case and the history of neuromodulation in effectively treating neuropathic pain, we submit that neuromodulation is a viable option for patients with refractory post-COVID-19 neuropathic pain.
Authors
- Casey Butler
Institutions
- Mayo Clinic Health System (US)
Publication Details
- Journal
- PubMed
- Published
- 2024-11-01
- Primary Topic
- Pain Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00